What is the quality of drug safety information for patients: An analysis of REMS educational materials

BACKGROUND: Poor‐quality patient drug information has been identified as a major cause of preventable medication errors in the United States. The US Food and Drug Administration (FDA) has the authority to require marketing authorization holders of medicinal products to implement risk evaluation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Hilda W., Russell, Andrea M., Smith, Meredith Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646909/
https://www.ncbi.nlm.nih.gov/pubmed/30003610
http://dx.doi.org/10.1002/pds.4614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646909/
https://www.ncbi.nlm.nih.gov/pubmed/30003610
http://dx.doi.org/10.1002/pds.4614

Ejemplares similares